Altria vs. Philip Morris: Which Stock Smokes Out Better Returns?

Altria (MO) and Philip Morris International (PM) reported Q2 2025 results reflecting their distinct strategic paths within a transforming tobacco industry. Altria posted an 8.3% increase in adjusted EPS and raised its full-year guidance, driven by robust growth in its 'on!' nicotine pouch brand and resilient pricing in combustibles, despite a 10.2% decline in domestic cigarette shipments. Philip Morris International saw smoke-free products account for 41% of net revenues, growing 15.2%, and lifted its full-year EPS guidance, propelled by its IQOS platform and significant cost efficiencies, even as combustible volumes declined. While Altria offers an attractive valuation for income investors and recently outperformed PM in stock performance, the analysis concludes PM presents stronger long-term growth potential due to its global scale and accelerating smoke-free transformation.

Analysis

Altria Group (MO) and Philip Morris International (PM) both demonstrated resilience in their Q2 2025 earnings, though their strategic paths and growth drivers are diverging significantly. Altria showcased strong domestic performance, with adjusted EPS rising 8.3% to $1.44 and a raised full-year EPS guidance of $5.35-$5.45. This was primarily fueled by robust pricing in its smokeable segment, where Marlboro's share expanded to 59.5%, and exceptional growth in its oral tobacco unit, where 'on!' nicotine pouch shipments surged 26.5%. However, this strength is set against a significant structural headwind, evidenced by a 10.2% decline in domestic cigarette shipment volumes. In contrast, Philip Morris's growth is increasingly powered by its global smoke-free platform, which now constitutes 41% of total net revenues and grew 15.2% organically. PM raised its full-year adjusted EPS guidance to $7.43-$7.56, implying 13-15% growth, supported by the success of IQOS and significant cost efficiencies, with over $1.2 billion in gross savings realized toward a $2 billion goal. While PM also faces combustible volume declines (down 1.5%), its international scale and advanced progress in its smoke-free transition give it a clearer long-term growth trajectory, justifying its premium forward P/E multiple of 21.25 compared to Altria's 12.29.

Key Decisions for Investors

• Investors seeking long-term growth should favor Philip Morris, as its smoke-free products now account for 41% of revenue and its forecasted EPS growth of 13-15% significantly outpaces Altria's.
• Income-focused investors may find Altria attractive due to its lower forward P/E of 12.29 and resilient earnings from pricing power, but must closely monitor the steep 10.2% decline in domestic cigarette shipment volumes as a key risk factor.
• Consider that while Altria's stock has recently outperformed, Philip Morris's premium valuation is supported by its more advanced smoke-free transformation and aggressive $2 billion cost-saving initiative, which provides a stronger buffer against combustible volume declines.
• The primary forward-looking indicator for both companies is the competitive performance of their respective next-generation products, specifically Altria's 'on!' versus PM's IQOS and ZYN, which will dictate future market share and profitability.